Q9H0E7 (UBP44_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 103.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ubiquitin carboxyl-terminal hydrolase 44 EC=3.4.19.12 Alternative name(s): Deubiquitinating enzyme 44 Ubiquitin thioesterase 44 Ubiquitin-specific-processing protease 44 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 712 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Deubiquitinase that plays a key regulatory role in the spindle assembly checkpoint or mitotic checkpoint by preventing premature anaphase onset. Acts by specifically mediating deubiquitination of CDC20, a negative regulator of the anaphase promoting complex/cyclosome (APC/C). Deubiquitination of CDC20 leads to stabilize the MAD2L1-CDC20-APC/C ternary complex (also named mitotic checkpoint complex), thereby preventing premature activation of the APC/C. Promotes association of MAD2L1 with CDC20 and reinforces the spindle assembly checkpoint. Acts as a negative regulator of histone H2B (H2BK120ub1) ubiquitination. Ref.6 Ref.10 |
| Catalytic activity | Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal). Ref.5 Ref.6 Ref.7 |
| Subcellular location | Nucleus. Note: Peaks in interphase, with relatively low levels maintained throughout mitosis By similarity. Ref.7 |
| Tissue specificity | Expressed in testis. Expressed at high levels in T-cell acute lymphoblastic leukemia. Ref.5 Ref.9 |
| Developmental stage | Elevated in mitosis; levels increase in mitotic cells and rapidly decrease once cells have completed chromosome attachment and exit from mitosis. Ref.6 |
| Induction | Transcriptionally regulated by POU5F1/OCT4 in embryonic stem cells and embryonal carcinoma cells. Ref.8 |
| Post-translational modification | Dephosphorylated by CTDP1. Ref.6 Ref.11 Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination and is degraded by the proteasome. Ref.7 |
| Sequence similarities | Belongs to the peptidase C19 family. USP44 subfamily. Contains 1 UBP-type zinc finger. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 712 | 712 | Ubiquitin carboxyl-terminal hydrolase 44 | PRO_0000080673 | |||||
Regions | |||||||||
| Zinc finger | 27 – 88 | 62 | UBP-type | ||||||
Sites | |||||||||
| Active site | 282 | 1 | Nucleophile | ||||||
| Active site | 636 | 1 | Proton acceptor By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 169 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 239 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 269 | 1 | Phosphothreonine Probable | ||||||
| Modified residue | 401 | 1 | Phosphoserine Probable | ||||||
Natural variations | |||||||||
| Natural variant | 91 | 1 | T → A. Ref.1 Ref.2 Ref.4 Corresponds to variant rs3812813 [ dbSNP | Ensembl ]. | VAR_017125 | |||||
| Natural variant | 316 | 1 | E → Q. Corresponds to variant rs7305024 [ dbSNP | Ensembl ]. | VAR_057043 | |||||
| Natural variant | 348 | 1 | R → G. Corresponds to variant rs7135642 [ dbSNP | Ensembl ]. | VAR_057044 | |||||
Experimental info | |||||||||
| Mutagenesis | 282 | 1 | C → S or A: Abolishes deubiquitinase activity. Ref.6 Ref.7 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs." Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S., Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W., Ottenwaelder B., Obermaier B. Poustka A.Genome Res. 11:422-435(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ALA-91. Tissue: Testis. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ALA-91. Tissue: Testis. |
| [3] | "The finished DNA sequence of human chromosome 12." Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R. Gibbs R.A.Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ALA-91. Tissue: Testis. |
| [5] | "Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases." Quesada V., Diaz-Perales A., Gutierrez-Fernandez A., Garabaya C., Cal S., Lopez-Otin C. Biochem. Biophys. Res. Commun. 314:54-62(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, ENZYME ACTIVITY. |
| [6] | "Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities." Stegmeier F., Rape M., Draviam V.M., Nalepa G., Sowa M.E., Ang X.L., McDonald E.R. III, Li M.Z., Hannon G.J., Sorger P.K., Kirschner M.W., Harper J.W., Elledge S.J. Nature 446:876-881(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, PHOSPHORYLATION, DEVELOPMENTAL STAGE, MUTAGENESIS OF CYS-282. |
| [7] | "K48- and K63-linked polyubiquitination of deubiquitinating enzyme USP44." Suresh B., Ramakrishna S., Lee H.J., Choi J.H., Kim J.Y., Ahn W.S., Baek K.H. Cell Biol. Int. 34:799-808(2010) [PubMed] [Europe PMC] [Abstract] Cited for: CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, UBIQUITINATION, MUTAGENESIS OF CYS-282. |
| [8] | "A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells." Jung M., Peterson H., Chavez L., Kahlem P., Lehrach H., Vilo J., Adjaye J. PLoS ONE 5:E10709-E10709(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [9] | "Overexpression of ubiquitin specific protease 44 (USP44) induces chromosomal instability and is frequently observed in human T-cell leukemia." Zhang Y., van Deursen J., Galardy P.J. PLoS ONE 6:E23389-E23389(2011) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [10] | "RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation." Fuchs G., Shema E., Vesterman R., Kotler E., Wolchinsky Z., Wilder S., Golomb L., Pribluda A., Zhang F., Haj-Yahya M., Feldmesser E., Brik A., Yu X., Hanna J., Aberdam D., Domany E., Oren M. Mol. Cell 46:662-673(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [11] | "Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit." Visconti R., Palazzo L., Della Monica R., Grieco D. Nat. Commun. 3:894-894(2012) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-169; SER-239; THR-269 AND SER-401, DEPHOSPHORYLATION. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AL136825 mRNA. Translation: CAB66759.1. AK315697 mRNA. Translation: BAG38060.1. AC018475 Genomic DNA. No translation available. BC030704 mRNA. Translation: AAH30704.1. |
| IPI | IPI00030306. |
| RefSeq | NP_001035862.1. NM_001042403.1. NP_115523.2. NM_032147.2. |
| UniGene | Hs.646421. |
3D structure databases | |
| ProteinModelPortal | Q9H0E7. |
| SMR | Q9H0E7. Positions 29-86, 268-678. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9H0E7. 11 interactions. |
| STRING | 9606.ENSP00000258499. |
Protein family/group databases | |
| MEROPS | C19.057. |
PTM databases | |
| PhosphoSite | Q9H0E7. |
Polymorphism databases | |
| DMDM | 300669621. |
Proteomic databases | |
| PaxDb | Q9H0E7. |
| PRIDE | Q9H0E7. |
Protocols and materials databases | |
| DNASU | 84101. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000258499; ENSP00000258499; ENSG00000136014. ENST00000393091; ENSP00000376806; ENSG00000136014. ENST00000537435; ENSP00000442629; ENSG00000136014. |
| GeneID | 84101. |
| KEGG | hsa:84101. |
| UCSC | uc001teg.3. human. |
Organism-specific databases | |
| CTD | 84101. |
| GeneCards | GC12M095910. |
| H-InvDB | HIX0010895. |
| HGNC | HGNC:20064. USP44. |
| HPA | HPA026543. |
| MIM | 610993. gene. |
| neXtProt | NX_Q9H0E7. |
| PharmGKB | PA134931457. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG5077. |
| HOGENOM | HOG000015084. |
| HOVERGEN | HBG018027. |
| InParanoid | Q9H0E7. |
| KO | K11834. |
| OMA | AIKSQNY. |
| OrthoDB | EOG4XGZZK. |
| PhylomeDB | Q9H0E7. |
Gene expression databases | |
| ArrayExpress | Q9H0E7. |
| Bgee | Q9H0E7. |
| CleanEx | HS_USP44. |
| Genevestigator | Q9H0E7. |
| GermOnline | ENSG00000136014. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.30.40.10. 1 hit. |
| InterPro | IPR018200. Pept_C19ubi-hydrolase_C_CS. IPR001394. Peptidase_C19. IPR013083. Znf_RING/FYVE/PHD. IPR001607. Znf_UBP. [Graphical view] |
| Pfam | PF00443. UCH. 1 hit. PF02148. zf-UBP. 1 hit. [Graphical view] |
| SMART | SM00290. ZnF_UBP. 1 hit. [Graphical view] |
| PROSITE | PS00972. UCH_2_1. 1 hit. PS00973. UCH_2_2. 1 hit. PS50235. UCH_2_3. 1 hit. PS50271. ZF_UBP. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 84101. |
| NextBio | 73349. |
| SOURCE | Search... |
Entry information
| Entry name | UBP44_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9H0E7 Secondary accession number(s): B2RDW3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
